+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

YOUNG INVESTIGATOR AWARD IN PEDIATRIC BRAIN TUMORS

American Society of Clinical Oncology (ASCO)

Purpose

The Conquer Cancer Young Investigator Award (YIA) in Pediatric Brain Tumors provides funding to promising investigators to encourage and promote quality research in focus areas of pediatric brain tumor research, with the goal of advancing the understanding and treatment of pediatric brain tumors. The purpose of this award is to fund physicians during the transition from a fellowship or training program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of an experienced mentor in the proposed research area. Applications are accepted from U.S. and international applicants.

Funding Available

The total award amount is $50,000 for one year, payable in two equal installments. Conquer Cancer has funding for one YIA in Pediatric Brain Tumors, and will be awarded to the most meritorious applications evaluated for this competition.

AI Based Application Success Predictor

🏥 1. Strong Clinical Relevance (Top Predictor)

ASCO funding is highly patient- and clinic-focused:

Research must directly impact:
- Cancer treatment
- Patient outcomes
- Clinical decision-making

👉 Projects disconnected from clinical oncology practice are less competitive

🎯 2. Clear Impact on Patient Care

Successful proposals clearly demonstrate:

Improvements in:
- Survival
- Quality of life
- Toxicity management
Real-world applicability in oncology settings

👉 “Will this change how oncologists treat patients?” is central

🔄 3. Translational or Practice-Changing Potential

ASCO strongly favors:

Translational research (bench → bedside)
Clinical trials or observational clinical studies
Health services research (e.g., access, disparities, care delivery)

👉 Practice-changing potential significantly boosts success

👩‍⚕️ 4. Investigator Profile (Critical Predictor)

For different grant types:

Early-career (Young Investigator Award)

Strong training background
Clear mentorship plan

Mid-career (Career Development Award)

Proven publication record
Evidence of independence

👉 Investigator trajectory is heavily evaluated

🤝 5. Strong Mentorship & Institutional Support

Recognized mentor(s) with funding track record
Access to:
- Clinical trials infrastructure
- Patient populations
Institutional commitment (protected research time)

🧪 6. Feasible & Rigorous Study Design

Clear hypothesis and endpoints
Realistic patient recruitment plan
Appropriate statistical methods

👉 Feasibility is crucial—especially for early-career grants

🌍 7. Focus on Equity & Global Oncology

ASCO increasingly prioritizes:

Cancer care disparities
Access to care
Global oncology (LMIC-focused projects)

👉 Equity-focused proposals have rising success rates

📊 8. Measurable Outcomes & Deliverables

Defined endpoints (clinical, behavioral, or system-level)
Clear timeline and milestones

💰 9. Realistic Budget

Modest, well-justified funding requests
Alignment with project scope

📑 10. Proposal Clarity & Alignment with Award Type

Tailored to specific ASCO grant mechanism
Clear, concise writing
Strict adherence to guidelines

📊 Summary: Key Predictors (Ranked)

Highest impact factors:

Clinical relevance & patient impact
Translational/practice-changing potential
Investigator strength (and mentorship for early-career)

Moderate predictors:
4. Study design & feasibility
5. Institutional support
6. Alignment with ASCO grant type

Supporting factors:
7. Equity/global oncology focus
8. Budget clarity
9. Proposal quality

💡 Insider Insight

Compared to AACR:

👉 American Society of Clinical Oncology is more clinically driven

AACR → biology & innovation
ASCO → clinical application & patient outcomes

👉 The key success question is:
“Will this improve real-world cancer care?”

Specialties

Cancer

Oncology

Neurosciences

Pediatrics

Eligibility Requirements

Applicants must meet the following criteria:

• Be a physician (MD, DO, or international equivalent) working in any country. An MD, PhD is eligible if both degrees are completed prior to the start of the grant period.

• Be within the last two years of their final oncology subspecialty training or fellowship program at an academic medical institution at the time of application submission. Examples of a subspecialty training include, but are not limited to, a hematology-oncology fellowship, a surgical oncology fellowship, or a radiation oncology residency. An exception to this window may be granted under the following circumstances:

o Applicants in training programs where the protected research time or dedicated research year may occur during the first year of the training program or outside the last two years of training (ex: In surgical oncology fellowship programs, the dedicated research year may occur during the first year of the program) If you think that you may be eligible for an exception to this criterion, please contact grants@conquer.org with your CV.

o Applicants who have just completed their subspecialty training within three months of the application deadline.

• Be within 10 years of obtaining their medical degree at the time of application submission. An exception to this criterion may be granted to foreign medical graduates whose medical degree completion may fall outside of the 10-year cutoff. Please see the FAQ for more information or contact grants@conquer.org.

• Be planning an investigative career in oncology.

• Have a valid, active medical license in the country where the research will be conducted at the time of application.

• Be working in an oncology laboratory or clinical research setting.

• Have a mentor from the sponsoring institution in the proposed research field. If the mentor is not an ASCO member, a supporting letter from an ASCO member from the sponsoring institution must be included.

• Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, visit asco.org/membership.

• Be able to commit at least 60% of their time for research (applies to total effort, not just the proposed YIA project) during the award period.

Sponsor Details

Sponsor Institute/Organizations: American Society of Clinical Oncology (ASCO)

Sponsor Type: Corporate/Non-Profit

Address: 2318 Mill Road, Suite 800, Alexandria, VA 22314

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity